Xenon Pharmaceuticals Inc.

XENE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$62.26-0.65%

2026-08-03

Financials

Valuation Metrics

Xenon Pharmaceuticals Inc.'s Market Cap is $6.02B. At end of 2025 it was $3.55B. Ranked #1242 of 3,111 in US market (top 40%), #409 of 1,445 on NASDAQ (top 28%), #69 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 26%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$6.02B	US#1,242/3,111 Sec#69/269
Revenue	$0.00	US#2,980/3,111 Sec#205/269
Net Income	$-383M	US—/3,111 Sec—/269
Total Assets	$1.39B	US#2,289/3,111 Sec#75/269
Net Assets	$1.34B	US#1,568/3,111 Sec#50/269
Value
P/B	4.50x	US#2,108/3,111 Sec#133/269
P/S	802.45x	US#2,953/3,111 Sec#198/269
FCF Yield	-5.11%	US—/3,111 Sec—/269
Profitability
ROE	-28.64%	US#2,609/3,111 Sec#124/269
ROA	-27.63%	US#2,861/3,111 Sec#155/269
Revenue Growth	-100.00%	US#2,955/3,111 Sec#191/269
Financial Health
Debt Ratio	3.66%	US#33/3,111 Sec#10/269
Total Debt	$7M	US#2,841/3,111 Sec#213/269
FCF	$-307M	US#2,800/3,111 Sec#244/269
Cash	$546M	US#1,024/3,111 Sec#52/269
Current Ratio	27.79x	US#88/3,111 Sec#14/269
Performance
1Y Return	104.13%	US#275/3,111 Sec#81/269
1M Return	2.13%	US#995/3,111 Sec#65/269
From 52W High	-14.31%	US#1,268/3,111 Sec#84/269
1Y MDD	-18.40%	US#557/3,111 Sec#19/269
Trading
Volume	519,450 shares	US#1,730/3,111 Sec#163/269
Trading Value	$32M	US#1,393/3,111 Sec#88/269
Per Share
EPS	$-4.36	US—/3,111 Sec—/269
BPS	$7.34	US#2,008/3,111 Sec#97/269